National Health Investors Stock Forecast, Price & News

National Health Investors (NYSE:NHI) Frequently Asked Questions

Is National Health Investors a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" National Health Investors stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View analyst ratings for National Health Investors or view top-rated stocks.

How has National Health Investors' stock been impacted by Coronavirus (COVID-19)?

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NHI stock has decreased by 24.9% and is now trading at $53.24.
View which stocks have been most impacted by COVID-19.

Are investors shorting National Health Investors?

National Health Investors saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,350,000 shares, an increase of 18.4% from the October 31st total of 1,140,000 shares. Based on an average daily volume of 318,300 shares, the short-interest ratio is currently 4.2 days. Currently, 3.1% of the shares of the company are sold short.
View National Health Investors' Short Interest.

When is National Health Investors' next earnings date?

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, February 28th 2022.
View our earnings forecast for National Health Investors.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) announced its earnings results on Monday, November, 8th. The real estate investment trust reported $0.67 earnings per share for the quarter, missing the consensus estimate of $1.18 by $0.51. The real estate investment trust had revenue of $73.83 million for the quarter, compared to analysts' expectations of $74.21 million. National Health Investors had a trailing twelve-month return on equity of 9.20% and a net margin of 45.92%. National Health Investors's revenue for the quarter was down 12.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.42 EPS.
View National Health Investors' earnings history.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Monday, November 8th. Investors of record on Friday, December 31st will be given a dividend of $0.90 per share on Monday, January 31st. This represents a $3.60 dividend on an annualized basis and a yield of 6.76%. The ex-dividend date of this dividend is Thursday, December 30th.
View National Health Investors' dividend history.

Is National Health Investors a good dividend stock?

National Health Investors pays an annual dividend of $3.60 per share and currently has a dividend yield of 7.06%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. National Health Investors has been increasing its dividend for 20 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of National Health Investors is 115.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, National Health Investors will have a dividend payout ratio of 75.63% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.
View National Health Investors' dividend history.

What price target have analysts set for NHI?

7 analysts have issued 12 month target prices for National Health Investors' shares. Their forecasts range from $55.00 to $77.00. On average, they expect National Health Investors' stock price to reach $67.17 in the next year. This suggests a possible upside of 26.2% from the stock's current price.
View analysts' price targets for National Health Investors or view top-rated stocks among Wall Street analysts.

Who are National Health Investors' key executives?

National Health Investors' management team includes the following people:

• D. Eric Mendelsohn, President, Chief Executive Officer & Director
• John L. Spaid, Chief Financial Officer & Executive VP-Finance
• David Louis Travis, Chief Accounting Officer & Senior Vice President
• Kevin C. Pascoe, Chief Investment Officer
• Kristin Sallee Gaines, Chief Credit Officer

Who are some of National Health Investors' key competitors?

Some companies that are related to National Health Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Extra Space Storage (EXR), Ventas (VTR), Medical Properties Trust (MPW), CubeSmart (CUBE), Life Storage (LSI), Omega Healthcare Investors (OHI), Rayonier (RYN), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), PotlatchDeltic (PCH) and EPR Properties (EPR).
View all of NHI's competitors.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.58%), Goldman Sachs Group Inc. (2.37%), Macquarie Group Ltd. (2.18%), Bank of New York Mellon Corp (1.95%), Geode Capital Management LLC (1.85%) and American Century Companies Inc. (1.25%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors.

Which institutional investors are selling National Health Investors stock?

NHI stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Gradient Investments LLC, BlackRock Inc., Deutsche Bank AG, Millennium Management LLC, Two Sigma Advisers LP, CapWealth Advisors LLC, and Schonfeld Strategic Advisors LLC.
View insider buying and selling activity for National Health Investors or view top insider-selling stocks.

Which institutional investors are buying National Health Investors stock?

NHI stock was bought by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Macquarie Group Ltd., Nordea Investment Management AB, Barclays PLC, UBS Group AG, Nepsis Inc., American Century Companies Inc., and Cubist Systematic Strategies LLC. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors or or view top insider-buying stocks.

How do I buy shares of National Health Investors?

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $53.24.

How much money does National Health Investors make?

National Health Investors has a market capitalization of $2.44 billion and generates $332.81 million in revenue each year. The real estate investment trust earns $185.13 million in net income (profit) each year or $3.13 on an earnings per share basis.

How many employees does National Health Investors have?

National Health Investors employs 20 workers across the globe.

When was National Health Investors founded?

National Health Investors was founded in 1991.

What is National Health Investors' official website?

The official website for National Health Investors is www.nhireit.com.

Where are National Health Investors' headquarters?

National Health Investors is headquartered at 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at (615) 890-9100, via email at [email protected], or via fax at 615-225-3030.